Jung et al. showed that LXR agonist T0901317-induced hepatic steatosis was ameliorated by an ω-3 fatty acid (FA) diet, and this was accompanied by blunted upregulation of SREBP1-c and FAS expression caused by LXR activation18. The gene discussed is SREBF1; the disease is fatty liver disease.